ATP22 antibody targets the ATP22 protein (Atp22p), a mitochondrial translation factor essential for synthesizing subunit 6 (Atp6p) of the F₀ component of ATP synthase . This antibody is primarily utilized in mitochondrial research to investigate ATP synthase assembly defects and energy metabolism in yeast models.
Atp22p is localized in the mitochondrial inner membrane and is indispensable for F₀ assembly. Key functions include:
Translation of Atp6p: Atp22p facilitates the synthesis of mitochondrial-encoded subunit 6, a critical proton channel in ATP synthase .
F₀ Assembly: Loss of Atp22p disrupts oligomycin-sensitive ATPase activity, leading to defective oxidative phosphorylation .
Pleiotropic Effects: atp22 mutants exhibit secondary deficiencies in cytochrome oxidase due to impaired mitochondrial translation .
Studies employing ATP22 antibody have revealed:
Western blot analyses show that atp22 mutants (except strain N417) lack detectable subunit 6, confirming its role in Atp6p synthesis .
Subunits 8 and 9 of F₀ remain unaffected, indicating specificity to subunit 6 .
Partial revertants of atp22 null mutants carry ρ⁻ mitochondrial genomes fused to COX1/ATP6 chimeric genes, restoring limited ATPase activity .
These findings highlight Atp22p’s irreplaceability in endogenous ATP6 translation .
atp22 mutants display growth defects on non-fermentable carbon sources and spontaneous mtDNA deletions .
ATP22 antibody is instrumental in: